Acumen pharmaceuticals to report fourth quarter and full year 2021 financial results on march 28, 2022

Charlottesville, va. and carmel, ind., march 16, 2022 (globe newswire) -- acumen pharmaceuticals, inc. (nasdaq: abos), a clinical stage biopharmaceutical company focused on the development of novel targeted therapeutics for alzheimer's disease (ad), today announced that the company will report its financial results for the fourth quarter and full year 2021 on monday, march 28, 2022. the company will host a conference call and live audio webcast at 4:30 p.m. et to provide a business and financial update.
ABOS Ratings Summary
ABOS Quant Ranking